Immune Globulin (Human)-hipp (Subcutaneous) and Kisqali (600 MG Dose)
Determining the interaction of Immune Globulin (Human)-hipp (Subcutaneous) and Kisqali (600 MG Dose) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: immune globulin subcutaneous
Brand name: Cutaquig, Cuvitru, Hizentra, Vivaglobin, Xembify
Synonyms: Immune globulin (subcutaneous)
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Immune Globulin (Human)-hipp (Subcutaneous)-Kisqali Femara Co-Pack
- Immune Globulin (Human)-hipp (Subcutaneous)-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Immune Globulin (Human)-hipp (Subcutaneous)-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Immune Globulin (Human)-hipp (Subcutaneous)-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Immune Globulin (Human)-hipp (Subcutaneous)-Kitabis Pak
- Immune Globulin (Human)-hipp (Subcutaneous)-Kitabis Pak inhalation
- Kisqali (600 MG Dose)-Immune Globulin (Human)-ifas (IV)
- Kisqali (600 MG Dose)-Immune Globulin (Human)-klhw (Subcutaneous)
- Kisqali (600 MG Dose)-Immune globulin (intramuscular) IGIM
- Kisqali (600 MG Dose)-Immune globulin (intravenous) IGIV
- Kisqali (600 MG Dose)-Immune globulin and hyaluronidase Subcutaneous
- Kisqali (600 MG Dose)-Immune Globulin Injection (IM)